Advancing Dialogue About Consent and Molecular HIV Surveillance in the United States: Four Proposals Following a Federal Advisory Panel's Call for Major Reforms
Stephen Molldrem, Anthony K J Smith, Alexander McClelland
Abstract
Policy Points Molecular HIV surveillance and cluster detection and response (MHS/CDR) programs have been a core public health activity in the United States since 2018 and are the "fourth pillar" of the Ending the HIV Epidemic initiative launched in 2019. MHS/CDR has caused controversy, including calls for a moratorium from networks of people living with HIV. In October 2022, the Presidential Advisory Council on HIV/AIDS (PACHA) adopted a resolution calling for major reforms. We analyze the policy landscape and present four proposals to federal stakeholders pertaining to PACHA's recommendations about incorporating opt-outs and plain-language notifications into MHS/CDR programs.
Topics & Concepts
Human immunodeficiency virus (HIV)Advisory committeePolitical sciencePublic administrationPresidential systemPillarFamily medicinePublic relationsMedicineLawPoliticsEngineeringStructural engineeringEthics in Clinical ResearchPublic Health Policies and EducationHIV, Drug Use, Sexual Risk